Philips deploys hospital monitor kits to ramp up ICU capacity against COVID-19

With 20 pairs of MX450 displays and MMX vital sign servers, Philips rapid deployment kits aim to wire up and connect standard hospital beds to provide critical care monitoring. (Philips)

Philips launched a new initiative to help healthcare providers transform their standard hospital rooms into connected critical care suites, allowing them to quickly increase capacity when facing surges of COVID-19 cases or in response to other natural disasters and pandemics.

The company’s rapid equipment deployment kits include fully configured ICU monitors and vital sign measurement servers, prepacked into sturdy, transportable containers. According to Philips, the kits can connect 20 beds to a central patient monitoring station and be up and running in an average of five hours.

“The current health crisis has demonstrated a clear need for us to deliver innovative solutions to our customers that provide a complete critical care monitoring solution with all of the equipment they require on demand,” said Peter Ziese, general manager of monitoring analytics at Philips. “This eliminates the need to source and configure individual pieces of high-demand equipment during a crisis.”

Event

Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.
Philips' Rapid Equipment Deployment
Initiative kits pack down into sturdy,
transportable containers. (Philips)
 

RELATED: To screen COVID-19 patients for heart problems, FDA clears several ultrasound, AI devices from Philips, Eko, Caption Health 

The emergency ramp-up kits include deployment instructions, plus remote technical support from Philips, and have already been used in U.S. health systems, the company said. Meanwhile, the monitoring equipment—including MX450 displays and MMX vital sign servers—are equipped with predictive algorithms to alert care teams to deteriorating patients. 

After a crisis has passed, the kits can be disinfected, repacked and stored for future emergencies, or transferred from hospital to hospital as needed.

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.